GlassScriptPhysician profile
Gerardo F Ferrer
NPI 1598103491
$1,647.64
in general payments reported to CMS, 2019-2025
16 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $81.52 · 2021: $186 · 2022: $425 · 2023: $544 · 2024: $80.38 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $793.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $316.64 | 2022-2024 | Uzedy, Austedo, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $274.60 | 2019-2025 | Abilify Maintena, Abilify Asimtufii |
| Alkermes, INC. | $212.51 | 2019-2025 | Aristada, Lybalvi |
| Sunovion Pharmaceuticals INC. | $184.96 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $162.41 | 2022-2023 | Spravato, Invega Sustenna |
| Abbvie INC. | $117.70 | 2021-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $84.07 | 2022-2024 | Caplyta |
| Neurocrine Biosciences, INC. | $61.66 | 2021-2022 | |
| Medtronic, INC. | $59.02 | 2023 | Intellis Adaptivestim |
| Allergan, INC. | $42.14 | 2019-2020 | |
| Indivior INC. | $28.24 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $24.94 | 2025 | Cobenfy |
| Baudax Bio INC. | $24.81 | 2022 | |
| Lundbeck LLC | $23.21 | 2021 | |
| Idorsia Pharmaceuticals US INC | $19.07 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pierre Fabre Pharmaceuticals, INC. | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerardo Ferrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.